Video

Darolutamide plus ADT and radiotherapy improves metastasis free survival in very high risk prostate cancer

ESMO 2026: Surgery in high-risk localised prostate cancer

Omega-3 EPA improves overall survival after colorectal cancer liver metastasis resection

Updated survival and ctDNA findings support adjuvant cemiplimab in high-risk CSCC

Long-term survival benefits of abiraterone in de novo metastatic prostate cancer

Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC

Tarlatamab plus durvalumab improves survival in extensive-stage small cell lung cancer

Real-world outcomes with tarlatamab in previously treated ES-SCLC

Risvutatug rezetecan improves PFS in relapsed or refractory osteosarcoma

Reduced dosing frequency of immune checkpoint inhibitors raises survival concerns in advanced cancer

Pembrolizumab improves PFS and QoL in dMMR advanced endometrial cancer

Sacituzumab tirumotecan reduces progression and death in recurrent endometrial cancer